Pharma M&A Watch: AstraZeneca shares slid after reports it held talks to buy Bristol Myers Squibb, a Princeton, N.J.-based cancer drugmaker, in a near-$400B deal that would reshape the global industry—though both sides declined to comment and regulators would likely scrutinize any move. Biotech in NJ: Rocket Pharmaceuticals (based in Cranbury) said early safety from its modified Phase 2 RP-A501 Danon disease trial looks promising, with no major safety concerns in the first three patients and FDA discussions underway. Plasma Supply & Funding: Thplasma, operating plasma collection centers in New Jersey and Pennsylvania, announced a $20M financing to expand its plasma therapeutics platform and biosimilar development. Identity Tech: 1Kosmos (Iselin) was named a Gartner Leader for identity verification, highlighting protection for high-risk account and passwordless trust moments. Cybersecurity: CareCloud began notifying about a breach affecting about 345,000 people, involving medical and financial data accessed via an AWS environment. AI in Insurance: Plymouth Rock launched home insurance quotes via ChatGPT across states including New Jersey. Manufacturing & Facilities: High Performance Systems published guidance on transparent pricing and engineering for commercial kitchen epoxy and urethane flooring, focusing on substrate prep and moisture mitigation. Gaming Deal: Ilitch Gaming completed full acquisition of Ocean Casino Resort in Atlantic City, taking the remaining 50% stake. PFAS Cleanup Milestone: BioLargo said its PFAS treatment system at Lake Stockholm, N.J. has run for six months and treated over two million gallons, meeting state and EPA standards. Securities Legal Deadlines: Kaplan Fox announced a securities class action against EquipmentShare (EQPT) with a Sept. 21, 2026 lead plaintiff deadline.